Alexander Kamb

4PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Sep 12, 2026
PLP1-triggered NOT gate to address neurotoxicity risk of PSMA-targeted prostate cancer therapy.

|Mar 02, 2022
A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo.

Mark L Sandberg, Xueyin Wang, Aaron D Martin

|Jan 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells.

Talar Tokatlian, Grace E Asuelime, Jee-Young Mock

|Jan 14, 2021
Cancer T-cell therapy: building the foundation for a cure.

Alexander Kamb, William Y Go

Pageof 1

Frequent Collaborators

1 joint publications

Mark L Sandberg

1 joint publications

Xueyin Wang

1 joint publications

Aaron D Martin

1 joint publications

Daniel P Nampe

1 joint publications

Grant B Gabrelow

1 joint publications

Chuck Z Li

1 joint publications

Michele E McElvain

1 joint publications

Wen-Hua Lee

1 joint publications

Sara Martire

1 joint publications

Fernando A Fisher

Frequent Collaborators

1 joint publications

Mark L Sandberg

1 joint publications

Xueyin Wang

1 joint publications

Aaron D Martin

1 joint publications

Daniel P Nampe

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us